Biosimilars & Biologics
The track is extensively spread over two days covering key aspects of Biosimilars: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization.
The track is extensively spread over two days covering key aspects of Biosimilars: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization.
The track will emphasize on CGT: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization.